Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

NCT03657849 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT03657849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03657849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
Lead sponsor
HealthPartners Institute
Phase
Not applicable
Overall status
Completed
Start date
July 18, 2018
Completion date
August 31, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enlarged lymph nodes (excluding infective)